Vasopressin Injection 200 units Recall: Subpotent
Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc.…
What is the FDA recall status?
The FDA record lists this recall as terminated. This does not establish that a retained recalled product is safe to consume or use. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions.
Why was Vasopressin Injection 200 units recalled?
Subpotent product in addition to having out-of-specification results for impurities.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01
Which lot codes, UPCs or models are affected?
Lot #: 23061L1C0, Exp 1/31/2025
- Agency record number
- D-0507-2024
- Product
- Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc.…
- Recalling firm
- American Regent, Inc.
- Quantity
- 2,352 vials
- Distribution
- USA Nationwide
- Recall started
- May 13, 2024
- Report date
- May 29, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)